Zoetis Inc. (ZTS): Price and Financial Metrics

ZTS POWR Grades

• ZTS scores best on the Quality dimension, with a Quality rank ahead of 94.57% of US stocks.
• The strongest trend for ZTS is in Growth, which has been heading down over the past 179 days.
• ZTS ranks lowest in Momentum; there it ranks in the 15th percentile.

ZTS Stock Summary

• ZTS has a higher market value than 97.24% of US stocks; more precisely, its current market capitalization is $74,781,348,228.
• ZTS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 582.07 -- higher than 95.09% of US-listed equities with positive expected earnings growth.
• Price to trailing twelve month operating cash flow for ZTS is currently 39.11, higher than 89.01% of US stocks with positive operating cash flow.
• If you're looking for stocks that are quantitatively similar to ZOETIS INC, a group of peers worth examining would be BSX, ABB, BDX, SYK, and A.
• ZTS's SEC filings can be seen here. And to visit ZOETIS INC's official web site, go to www.zoetis.com.

ZTS Valuation Summary

• In comparison to the median Healthcare stock, ZTS's EV/EBIT ratio is 327.48% higher, now standing at 28.
• ZTS's EV/EBIT ratio has moved down 12.9 over the prior 123 months.

Below are key valuation metrics over time for ZTS.

ZTS Growth Metrics

The 3 year net income to common stockholders growth rate now stands at 49.35%.
• Its year over year cash and equivalents growth rate is now at -12.97%.
• Its year over year net income to common stockholders growth rate is now at 16.85%.

Over the past 34 months, ZTS's revenue has gone up $1,741,000,000.

The table below shows ZTS's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	8,080	1,912	2,114
2022-09-30	8,007	1,850	2,067
2022-06-30	7,995	1,977	2,090
2022-03-31	7,891	2,122	2,073
2021-12-31	7,776	2,213	2,037
2021-09-30	7,616	2,252	1,982

ZTS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ZTS has a Quality Grade of A, ranking ahead of 95.14% of graded US stocks.
• ZTS's asset turnover comes in at 0.552 -- ranking 69th of 682 Pharmaceutical Products stocks.
• UTHR, ENDP, and MYGN are the stocks whose asset turnover ratios are most correlated with ZTS.

The table below shows ZTS's key quality metrics over time.